PALO ALTO, Calif., Oct. 1 /PRNewswire/ -- Anacor Pharmaceuticals, Inc., a privately held company, today announced that it has appointed Paul Cleveland to its board of directors and as Chairman of its Audit Committee. Mr. Cleveland is currently the Chief Financial Officer and Executive Vice President of Corporate Development at Affymax (Nasdaq: AFFY - News), a position he has held since January 2006.
